# LANdiolol MIcrocirculatory Effects During Septic chOc (MILANOS)

> **NCT04931225** · PHASE3 · RECRUITING · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 44 (estimated)

## Conditions studied

- Septic Shock

## Interventions

- **DRUG:** Landiolol

## Key facts

- **NCT ID:** NCT04931225
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-07-18
- **Primary completion:** 2026-07
- **Final completion:** 2026-07
- **Target enrollment:** 44 (ESTIMATED)
- **Last updated:** 2025-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04931225

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04931225, "LANdiolol MIcrocirculatory Effects During Septic chOc (MILANOS)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04931225. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*